Deployment of a transportable Yb optical lattice clock.

We report on the first deployment of a ytterbium (Yb) transportable optical lattice clock (TOLC), commercially shipping the clock 3000 km from Boulder, Colorado, to Washington DC. The system, composed of a rigidly mounted optical reference cavity, an atomic physics package, and an optical frequency comb, fully realizes an independent frequency standard for comparisons in the optical and microwave domains. The shipped Yb TOLC was fully operational within 2 days of arrival, enabling frequency comparison with a rubidium (Rb) fountain at the United States Naval Observatory (USNO).

Post-acute sequela of COVID-19 infection in individuals with multiple sclerosis.

Background: Many common symptoms in post-acute sequelae following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) overlap with those of multiple sclerosis (MS). We examined symptoms and performance of the PASC score, developed in the general population, in MS based on infection history.

Methods: We surveyed North American Research Committee on Multiple Sclerosis (NARCOMS) registry participants regarding infections and categorized participants based on infection history.

Effects of COVID-19 Infection on Symptom Severity and Disability in Multiple Sclerosis.

Background And Objectives: Infections, including infection with SARS-CoV-2 (COVID-19), could alter the course of multiple sclerosis (MS). Previous studies assessing the effects of COVID-19 on MS outcomes were small and had discordant findings. The study objective was to evaluate the association of COVID-19 infection with changes in the trajectory of MS symptoms and disability.

Web-based pain coping skills training (PCST) for managing aromatase inhibitor-associated arthralgia in breast cancer survivors: Randomized controlled trial protocol.

Background: Aromatase inhibitors (AIs) are a cornerstone of adjuvant systemic therapy for postmenopausal patients with hormone-receptor positive (HR+) breast cancer. Although AIs decrease cancer recurrence rates and improve survival rates, approximately 50 % of patients experience arthralgia-persistent pain related to worse patient outcomes and poor AI adherence. Current medical interventions for AI-associated arthralgia have limited efficacy and side effects that restrict their use among older patients.